176 related articles for article (PubMed ID: 32083780)
1. Landscape of current and future therapies of Merkel cell carcinoma.
Kwiatkowska D; Reich A
Dermatol Ther; 2020 May; 33(3):e13281. PubMed ID: 32083780
[TBL] [Abstract][Full Text] [Related]
2. [Immune checkpoint inhibition in Merkel cell carcinoma].
Terheyden P; Mohr A; Langan EA
Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell polyomavirus-specific and CD39
Ryu H; Bi TM; Pulliam TH; Sarkar K; Church CD; Kumar N; Mayer-Blackwell K; Jani S; Ramchurren N; Hansen UK; Hadrup SR; Fling SP; Koelle DM; Nghiem P; Newell EW
Cell Rep Med; 2024 Feb; 5(2):101390. PubMed ID: 38340724
[TBL] [Abstract][Full Text] [Related]
4. Global PD-L1 Signals and Tumor-Infiltrating Lymphocytes: Markers of Immunogenicity in Different Subsets of Merkel Cell Carcinoma and Potential Therapeutic Implications.
Walsh NM; Castonguay MC; Carter MD; Pasternak S; Ly TY; Doucette S; Hanly JG; Saggini A; Cerroni L
Am J Dermatopathol; 2019 Nov; 41(11):819-825. PubMed ID: 31634167
[TBL] [Abstract][Full Text] [Related]
5. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
Knepper TC; Montesion M; Russell JS; Sokol ES; Frampton GM; Miller VA; Albacker LA; McLeod HL; Eroglu Z; Khushalani NI; Sondak VK; Messina JL; Schell MJ; DeCaprio JA; Tsai KY; Brohl AS
Clin Cancer Res; 2019 Oct; 25(19):5961-5971. PubMed ID: 31399473
[TBL] [Abstract][Full Text] [Related]
6. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options.
Gehrcken L; Sauerer T; Schaft N; Dörrie J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445385
[TBL] [Abstract][Full Text] [Related]
7. Current and preclinical treatment options for Merkel cell carcinoma.
Celikdemir B; Houben R; Kervarrec T; Samimi M; Schrama D
Expert Opin Biol Ther; 2023; 23(10):1015-1034. PubMed ID: 37691397
[TBL] [Abstract][Full Text] [Related]
8. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options.
Hernandez LE; Mohsin N; Yaghi M; Frech FS; Dreyfuss I; Nouri K
Dermatol Ther; 2022 Mar; 35(3):e15292. PubMed ID: 34967084
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in Merkel cell carcinoma.
Robinson CG; Tan D; Yu SS
F1000Res; 2019; 8():. PubMed ID: 31824653
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Björnhagen V; Höög A; Lee L; Larsson C; Lui WO
Int J Cancer; 2020 Mar; 146(6):1652-1666. PubMed ID: 31180579
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.
Samimi M; Gardair C; Nicol JT; Arnold F; Touzé A; Coursaget P
Semin Oncol; 2015 Apr; 42(2):347-58. PubMed ID: 25843739
[TBL] [Abstract][Full Text] [Related]
15. Human Merkel cell polyomavirus: virological background and clinical implications.
Coursaget P; Samimi M; Nicol JT; Gardair C; Touzé A
APMIS; 2013 Aug; 121(8):755-69. PubMed ID: 23781869
[TBL] [Abstract][Full Text] [Related]
16. [Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia? : Novel concept about the cellular origin of Merkel cell carcinoma].
Sauer CM; Chteinberg E; Rennspiess D; Kurz AK; Zur Hausen A
Hautarzt; 2017 Mar; 68(3):204-210. PubMed ID: 28194491
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
Barkdull S; Brownell I
Cancer Biol Ther; 2017 Dec; 18(12):937-939. PubMed ID: 29172995
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of ulceration and hyperkeratosis as clinical predictors of Merkel cell polyomavirus-negative and combined Merkel cell carcinoma: A retrospective study.
Nagase K; Kimura-Kaku H; Inoue T; Shinogi T; Narisawa Y
J Dermatol; 2019 Feb; 46(2):103-109. PubMed ID: 30565285
[TBL] [Abstract][Full Text] [Related]
19. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
20. [Merkel-cell carcinoma].
Moll I
Pathologe; 2019 Dec; 40(Suppl 3):350-354. PubMed ID: 31820040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
